ALID (Allied) Change In Receivables : $0.05 Mil (TTM As of May. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Allied Change In Receivables?

Allied's change in receivables for the quarter that ended in May. 2024 was $-0.29 Mil. It means Allied's Accounts Receivable increased by $0.29 Mil from Feb. 2024 to May. 2024 .

Allied's change in receivables for the fiscal year that ended in Aug. 2023 was $0.54 Mil. It means Allied's Accounts Receivable declined by $0.54 Mil from Aug. 2022 to Aug. 2023 .

Allied's Accounts Receivable for the quarter that ended in May. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Allied's Days Sales Outstanding for the three months ended in May. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Allied's liquidation value for the three months ended in May. 2024 was $-9.63 Mil.

Allied Change In Receivables Historical Data

The historical data trend for Allied's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Change In Receivables Chart

Allied Annual Data

Trend

Mar18

Mar19

Aug20

Aug21

Aug22

Aug23

Change In Receivables

Get a 7-Day Free Trial

0.03

0.09

-0.12

0.54

Allied Quarterly Data
	Jun19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Change In Receivables	Get a 7-Day Free Trial															-0.09	0.16	0.10	0.08	-0.29

Allied Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.

Allied (OTCPK:ALID) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Allied's Days Sales Outstanding for the quarter that ended in May. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0.077	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Allied's accounts receivable are only considered to be worth 75% of book value:

Allied's liquidation value for the quarter that ended in May. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.092	-	9.895	+	0.75 * 0	+	0.5 * 0.343
=	-9.63

Allied Change In Receivables Related Terms

Thank you for viewing the detailed overview of Allied's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Allied Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Corp (OTCPK:ALID) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

1405 St. Paul Street, Suite 201, Kelowna, BC, CAN, V1Y 9N2

Website

https://www.allied.health

Allied Corp is an international cannabis company with a mission to help people suffering from Post-Traumatic Stress Disorder (PTSD) by researching, creating, and producing targeted cannabinoid health solutions. The company uses an evidence-informed scientific approach to make this mission possible through cutting-edge pharmaceutical research and development, plant-based production, and the development of therapeutic products. The company operates in two segments which include Allied and Allied Colombia. Its geographical segments consist of Colombia and Canada. The company's revenue is comprised ofsales ofcannabis products.

Executives

James George Robinson	director, 10 percent owner	10 EAST LEE STREET, SUITE 2705, BALTIMORE MD 21202
Anthony Zelen	director, 10 percent owner	1406 MINE HILL LANE, KELOWNA A1 V1P 1S5
Calum Hughes	director, 10 percent owner, officer: Chief Executive Officer	1847 CROSSGLEN COURT, KELOWNA A1 V1V 1S4
David Weinkauf	director, 10 percent owner, officer: Chief Business Development Off	192 SIERRA MORENA LANDING, SW CALGARY A0 T3H 4K4
Paul James Bullock	director, 10 percent owner, officer: Chief Operating Officer	1400 ST PAUL ST, SUITE 201, KELOWNA Z4 V1Y9N2